Terms: = Germ cell tumor AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Treatment
320 results:
1. Combined therapy of dabrafenib and an anti-her2 antibody-drug conjugate for advanced BRAF-mutant melanoma.
Li W; Zheng C; Xu X; Xia Y; Zhang K; Huang A; Zhang X; Zheng Y; Chen G; Zhang S
Cell Mol Biol Lett; 2024 Apr; 29(1):50. PubMed ID: 38594618
[TBL] [Abstract] [Full Text] [Related]
2. [neuroendocrine Carcinoma of the Non-Ampullary Duodenum-A Case Report].
Tsukamoto T; Edagawa E; Togano S; Hori T; Tsujio G; Kunimoto T; Kaizaki R; Inoue T; Takatsuka S; Fukushima H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1700-1702. PubMed ID: 38303178
[TBL] [Abstract] [Full Text] [Related]
3. Prioritization of Fluorescence In Situ Hybridization (FISH) Probes for Differentiating Primary Sites of neuroendocrine tumors with Machine Learning.
Pietan L; Vaughn H; Howe JR; Bellizzi AM; Smith BJ; Darbro B; Braun T; Casavant T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139230
[TBL] [Abstract] [Full Text] [Related]
4. Systematic characterization of antibody-drug conjugate targets in central nervous system tumors.
Coy S; Lee JS; Chan SJ; Woo T; Jones J; Alexandrescu S; Wen PY; Sorger PK; Ligon KL; Santagata S
Neuro Oncol; 2024 Mar; 26(3):458-472. PubMed ID: 37870091
[TBL] [Abstract] [Full Text] [Related]
5. Use of Drugs in Clinical Practice and the Associated Cost of Cancer treatment in Adult Patients with Solid tumors: A 10-Year Retrospective Cohort Study.
Carreras MJ; Tomás-Guillén E; Farriols A; Renedo-Miró B; Valdivia C; Vidal J; Saura C; Carles J; Felip E; Gorgas MQ; Tabernero J; Monterde J
Curr Oncol; 2023 Aug; 30(9):7984-8004. PubMed ID: 37754495
[TBL] [Abstract] [Full Text] [Related]
6. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
7. Receptor conversion and survival in breast cancer liver metastases.
Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
[TBL] [Abstract] [Full Text] [Related]
8. Brave new world-new and emerging treatments for gastric cancer.
Lynch E; Duffy AG; Kelly RJ
Chin Clin Oncol; 2023 Oct; 12(5):54. PubMed ID: 37691344
[TBL] [Abstract] [Full Text] [Related]
9. Long-term survival in patients with brain metastases-clinical characterization of a rare scenario.
Hügel M; Stöhr J; Kuhnt T; Nägler F; Papsdorf K; Klagges S; Hambsch P; Güresir E; Nicolay NH; Seidel C
Strahlenther Onkol; 2024 Apr; 200(4):335-345. PubMed ID: 37646818
[TBL] [Abstract] [Full Text] [Related]
10. Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.
Zattarin E; Taglialatela I; Lobefaro R; Leporati R; Fucà G; Ligorio F; Sposetti C; Provenzano L; Azzollini J; Vingiani A; Ferraris C; Martelli G; Manoukian S; Pruneri G; de Braud F; Vernieri C
Crit Rev Oncol Hematol; 2023 Oct; 190():104109. PubMed ID: 37643668
[TBL] [Abstract] [Full Text] [Related]
11. Breast cancer vaccines; A comprehensive and updated review.
Al-Hawary SIS; Saleh EAM; Mamajanov NA; S Gilmanova N; Alsaab HO; Alghamdi A; Ansari SA; Alawady AHR; Alsaalamy AH; Ibrahim AJ
Pathol Res Pract; 2023 Sep; 249():154735. PubMed ID: 37611432
[TBL] [Abstract] [Full Text] [Related]
12. ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis.
Tew BY; Kalfa AJ; Yang Z; Hurth KM; Simon T; Abnoosian E; Durant ST; Hamerlik P; Salhia B
Clin Cancer Res; 2023 Nov; 29(21):4492-4503. PubMed ID: 37585496
[TBL] [Abstract] [Full Text] [Related]
13. Lung cancer with breast metastasis: a case report and review of the literature.
Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
[TBL] [Abstract] [Full Text] [Related]
14. Chimeric Antigen Receptor T cells in Glioblastoma-Current Concepts and Promising Future.
Kringel R; Lamszus K; Mohme M
Cells; 2023 Jul; 12(13):. PubMed ID: 37443804
[TBL] [Abstract] [Full Text] [Related]
15. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
Quddusi DM; Bajcinca N
IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
[TBL] [Abstract] [Full Text] [Related]
16. Gastric Amphicrine Carcinoma Showing neuroendocrine and Pancreatic Acinar cell Differentiation. Lesson from a Challenging Case Opening New Perspectives in the Diagnostic Work-Up of Gastric neuroendocrine Neoplasms.
Sciarra A; Uccella S; Hiroz P; Fournier I; Soubeyran V; Finzi G; La Rosa S
Endocr Pathol; 2023 Sep; 34(3):349-357. PubMed ID: 37249796
[TBL] [Abstract] [Full Text] [Related]
17. Intracranial injection of natural killer cells engineered with a her2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Burger MC; Forster MT; Romanski A; Straßheimer F; Macas J; Zeiner PS; Steidl E; Herkt S; Weber KJ; Schupp J; Lun JH; Strecker MI; Wlotzka K; Cakmak P; Opitz C; George R; Mildenberger IC; Nowakowska P; Zhang C; Röder J; Müller E; Ihrig K; Langen KJ; Rieger MA; Herrmann E; Bonig H; Harter PN; Reiss Y; Hattingen E; Rödel F; Plate KH; Tonn T; Senft C; Steinbach JP; Wels WS
Neuro Oncol; 2023 Nov; 25(11):2058-2071. PubMed ID: 37148198
[TBL] [Abstract] [Full Text] [Related]
18. Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours.
Mair MJ; Bartsch R; Le Rhun E; Berghoff AS; Brastianos PK; Cortes J; Gan HK; Lin NU; Lassman AB; Wen PY; Weller M; van den Bent M; Preusser M
Nat Rev Clin Oncol; 2023 Jun; 20(6):372-389. PubMed ID: 37085569
[TBL] [Abstract] [Full Text] [Related]
19. Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
[TBL] [Abstract] [Full Text] [Related]
20. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
[No Abstract] [Full Text] [Related]
[Next]